INVESTOR DEADLINE APPROACHING: Faruqi & Faruqi, LLP Investigates Claims on Behalf of Investors of Metagenomi
Faruqi & Faruqi is a leading national securities law firm with offices in New York, Pennsylvania, California and Georgia. The ...
Glancy Prongay & Murray LLP Reminds Investors Of Looming Deadline In The Class Action Lawsuit Against Metagenomi, Inc. (MGX)
On February 13, 2024, Metagenomi conducted its IPO, selling approximately 6.25 million shares at $15 per share. However, on May 1, 2024, less than three months after the IPO, Metagenomi announced that ...
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Fraud Lawsuit
BENSALEM, Pa., Oct. 7, 2024 /PRNewswire/ -- Law Offices of Howard G. Smith announces that investors with substantial losses ...
Metagenomi, Inc. Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The Schall Law Firm
NDAQ:MGX) Metagenomi, Inc. Is Being Sued For Possible Securities Fraud And Affected Shareholders Are Urged To Contact The ...
bovnews10d
Why Did Metagenomi Inc (MGX) Stock See -45.59% Plunge in the Last 90 Days?
On Friday, Metagenomi Inc (MGX) stock saw a modest uptick, ending the day at $2.22 which represents a slight increase of $0.18 or 8.82% from the prior close of $2.04. The stock opened at $2.08 and ...
bovnews7d
Metagenomi Inc (MGX) Stock Price Reaches $2.07: What Factors Are Influencing This Level?
On Tuesday, Metagenomi Inc (MGX) stock saw a decline, ending the day at $2.07 which represents a decrease of $-0.10 or -4.61% from the prior close of $2.17. The stock opened at $2.19 and touched a low ...
Business Wire11d
Glancy Prongay & Murray LLP, a Leading Securities Fraud Law Firm, Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Investors
Glancy Prongay & Murray LLP (“GPM”), a leading national shareholder rights law firm, announces that a class action lawsuit has been filed on behal ...
pharmaphorum24d
Metagenomi prices IPO and NeOnc joins list of hopefuls
Gene editing start-up Metagenomi and cancer specialist NeOnc Technologies have announced the terms of their initial public offerings, in another sign that investor interest in biotech is growing.
Yahoo Finance9d
Metagenomi, Inc. (MGX)
EMERYVILLE, Calif., Sept. 19, 2024 (GLOBE NEWSWIRE) -- Metagenomi, Inc. (Nasdaq: MGX), a precision genetic medicines company committed to developing curative therapeutics for patients using its ...
Nasdaq19d
Metagenomi to Present at Chardan's 8th Annual Genetic Medicines Conference
A live conference webcast of the fireside chat will be available in the investor section of the company's website at https://ir.metagenomi.co/. Replays for both events will be available for a ...
Business Wire11d
INVESTOR ALERT: Law Offices of Howard G. Smith Announces the Filing of a Securities Class Action on Behalf of Metagenomi, Inc. (MGX) Investors
Law Offices of Howard G. Smith announces that a class action lawsuit has been filed on behalf of investors who purchased Metagenomi, Inc. (“Metagenomi ...
Morningstar6d
MGX Investors Have Opportunity to Lead Metagenomi, Inc. Securities Lawsuit
NEW YORK, Oct. 3, 2024 /PRNewswire/ -- Rosen Law Firm, a global investor rights law firm, announces the filing of a class action lawsuit on behalf of purchasers of stock of Metagenomi ...